Frazier Management as of Dec. 31, 2019
Portfolio Holdings for Frazier Management
Frazier Management holds 20 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Phathom Pharmaceuticals (PHAT) | 38.0 | $227M | 7.3M | 31.14 | |
| Mirum Pharmaceuticals (MIRM) | 14.7 | $88M | 3.6M | 24.52 | |
| Krystal Biotech (KRYS) | 8.3 | $50M | 895k | 55.38 | |
| Iovance Biotherapeutics (IOVA) | 8.1 | $49M | 1.8M | 27.68 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 6.5 | $39M | 1.9M | 20.58 | |
| Anaptysbio Inc Common (ANAB) | 6.3 | $38M | 2.3M | 16.25 | |
| Gritstone Oncology Ord (GRTSQ) | 3.1 | $19M | 2.1M | 8.97 | |
| Translate Bio | 3.0 | $18M | 2.2M | 8.14 | |
| Aptinyx | 1.8 | $11M | 3.2M | 3.42 | |
| Alpine Immune Sciences | 1.7 | $9.9M | 2.6M | 3.84 | |
| Millendo Therapeutics | 1.6 | $9.4M | 1.4M | 6.74 | |
| Allena Pharmaceuticals | 1.5 | $9.1M | 3.3M | 2.73 | |
| Iterum Therapeutics | 1.2 | $6.9M | 1.5M | 4.50 | |
| Entasis Therapeutics Holdings Ord | 1.1 | $6.7M | 1.3M | 4.97 | |
| Nabriva Therapeutics | 0.9 | $5.6M | 4.3M | 1.32 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.8 | $5.0M | 1.3M | 3.84 | |
| Adverum Biotechnologies | 0.5 | $3.1M | 268k | 11.52 | |
| Sierra Oncology | 0.5 | $2.8M | 8.1M | 0.34 | |
| Bellicum Pharma | 0.2 | $1.4M | 1.1M | 1.29 | |
| Kezar Life Sciences | 0.1 | $363k | 91k | 4.01 |
